CVS, Cigna, and UnitedHealth inflated cancer and HIV drug prices, FTC saysByBen KesslenUpdatedYesterday
Eli Lilly's weight loss pill could get federal approval by early next yearByWilliam GavinPublishedJanuary 13, 2025
Trump's Ozempic tariffs, Zepbound on Medicare, and rising drug prices: Pharma news roundupByBruce GilPublishedJanuary 10, 2025
Google's anti-aging company just released 'disappointing' drug trial resultsByBruce GilPublishedJanuary 7, 2025
Results are in for a new depression drug trial, and they're cratering this stockByBruce GilPublishedJanuary 2, 2025
Weight loss drugs are changing the game, Eli Lilly exec says — but many still can't get themByBruce GilPublishedJanuary 2, 2025
The FDA says the Zepbound shortage is over. That's rattling the weight loss industryByBruce GilUpdatedDecember 19, 2024
CVS filled a 'massive' amount of invalid opioid prescriptions, the feds sayByWilliam GavinPublishedDecember 19, 2024
Weight loss drugs are getting people to the doctor. Now comes the wave of long-ignored diagnosesByBruce GilPublishedDecember 17, 2024
Ozempic could be linked to a common cause of sudden blindness, study findsByBruce GilUpdatedDecember 13, 2024
What can't weight-loss meds do? Eli Lilly is going to test obesity drugs as a treatment for addictionByBruce GilUpdatedDecember 11, 2024
Eli Lilly is partnering with Ro to make it easier than ever to get ZepboundByBruce GilPublishedDecember 11, 2024